Analytical quality by design approach to RP-HPLC method development and validation for simultaneous estimation of esomeprazole and naproxen in modified-release dosage form

Future Journal of Pharmaceutical Sciences

Table 5 Data of accuracy with placebo for recovery analysis for ESP

The concentration of sample with placebo μg/ml		Peak area of ESP		Recovered concentration μg/ml			% Recovery
Individual	Average	Sample	Standard	Individual	Average		% Recovery
8.10	8.11	72,099	90,584 (10.20 μg/ml)	8.12		8.13	100.23
8.18		72,448		8.16			99.73
8.05		72,026		8.11			100.75
10.05	10.08	89,630		10.09		10.10	100.42
10.11		89,695		10.10			99.90
10.08		89,654		10.10			100.15
12.20	12.19	109,138		12.29		12.26	100.73
12.14		108,515		12.22			100.65
12.22		108,914		12.26			100.36